Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.
D000203:Activities of Daily Living; D000339:Affect; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003071:Cognition; D003704:Dementia / Q000188:drug therapy* / Q000523:psychology; D000077265:Donepezil; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008559:Memantine / Q000627:therapeutic use*; D048448:Phenylcarbamates / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011788:Quality of Life; D000068836:Rivastigmine; D013619:Tacrine / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D005702:Galantamine; D013619:Tacrine; D000077265:Donepezil; D000068836:Rivastigmine; D008559:Memantine